Adapsyn Bioscience today announced that it has completed a round of financing that was co-funded by Pfizer R&D Innovate and Genesys Capital. Source: BioSpace

Although the stock market seems to be moving up at the beginning of this year, the U.S. equities market appears more mixed, with healthcare stocks in particular appearing more volatile.…

The BTD decision for voxelotor was based on clinical data submitted from a trio of studies. Source: BioSpace

Gene therapy treatment is a high risk, high reward venture, but the promises of a therapy developed through these programs could be life-changing for patients. Source: BioSpace

Cellectar Biosciences is closing its manufacturing operations and contracting them out. Source: BioSpace

For multiple perspectives on addressing this challenge, three respected individuals involved with the effort to bridge clinical research and clinical health care share their views. Source: BioSpace

Cantor Fitzgerald & Co. and Mizuho Securities USA LLC are acting as joint book-running managers for the offering. Source: BioSpace

The latest collaborations bring the total number of strategic transactions executed by J&J Innovation to more than 350 since its establishment in 2012. Source: BioSpace

About 200 of the job cuts will be in Massachusetts, the remaining in Connecticut. Source: BioSpace

The transaction was led by Signet Healthcare Partners in addition to Crestline Investors with other investors comprised of Cane Investment Partners and existing Leading Pharma members. Source: BioSpace